Characterization of asthmatic patients hospitalized with SARS-CoV-2 in a portuguese COVID-19 reference hospital
Revista Portuguesa de Imunoalergologia
; 30(2):111-120, 2022.
Article
in Portuguese
| EMBASE | ID: covidwho-1970022
ABSTRACT
Introduction:
People with chronic respiratory diseases, asthma included, may be at increased risk for severe COVID-19. However, published studies so far have reported inconsistent results regarding the prevalence of asthma.Objective:
The aim of this study was to characterize hospitalized patients with SARS-CoV-2 infection.Methods:
Retrospective observational study with analysis of hospitalized patients between March 1st and June 30rd.Results:
This study included 237 patients, with asthma being reported in 16 patients (6,8%). Asthmatic patients tended to be younger (70 years vs 80 years, p=0.027) and to have less comorbidities (1 vs 2 p=0.014) compared with non-asthmatic patients. Regarding the therapeutic approach, asthmatic patients required more inhaled corticosteroid therapy as well hydroxychloroquine, but the ceiling of treatment was less stablished (50% vs 21.7%, p=0.027;75% vs 48.9%, p=0.044;6.3% vs 38%, p=0.011, respectively). The mortality rate was lower compared with that of non-asthmatic patients (12.5% vs 37.1%, p=0.047). The severity of asthma did not seem to influence analysed outcomes.Conclusion:
In this study, asthma did not appear to contribute to the more severe COVID-19.
adult; article; asthma; comorbidity; controlled study; coronavirus disease 2019; corticosteroid therapy; drug therapy; female; hospital patient; human; major clinical study; male; mortality; mortality rate; nonhuman; observational study; retrospective study; Severe acute respiratory syndrome coronavirus 2; hydroxychloroquine
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Portuguese
Journal:
Revista Portuguesa de Imunoalergologia
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS